chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID Vaccine Breakthrough Case- Pfizer Dose 1 4/16/21 (NA), Pfizer Dose 2 5/13/21 (ER8736), COVID Positive 11/18/21. 11/18/21: 29 yo G4P3 at 29 4/7 wks. based on  first trimester US with EDD of 1/30/2022 presents for IOL secondary to 3rd trimester loss. Patient presented on 11/17/ for her visit. She was found to not have FHT. US was performed with breech presentation, fetal scalp edema, EFW <1%ile, and a cord around the baby's neck. Her husband was DX with COVID this week. She had US on 11/2 secondary to 20 wk. US with pyelectasis noted. Her US on 11/2 noted 70%ile EFW and resolved pyelectasis. She had US on 9/14 with 5mm R pyelectasis noted. She did not have genetic testing performed during this pregnancy. Her pregnancy is notable for- Obesity- H/o C-section (3rd pregnancy)- IUFD. She is appropriately tearful. Her husband is with her despite being COVID positive secondary to fetal loss situation. 11/20/21: t presented at 29-4 with IUFD and Covid. Laminaria were placed and induction was started. She eventually progress to complete and proceeded to deliver a stillborn female infant. See operative note for complete details. She tolerated the procedure well and was advanced per routine. She was ambulating, voiding, and tolerating PO, and was discharged to home on PPD #0.
became ill; diagnosed with COVID; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (became ill) and COVID-19 (diagnosed with COVID) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (became ill) and COVID-19 (diagnosed with COVID). At the time of the report, ILLNESS (became ill) and COVID-19 (diagnosed with COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment includes Monoclonal antibody infusion
p/vax pt exp pain, swelling & redness @ the inj site;pt devel a pruritic rash over inj site which progressed to lt arm;devel mild asthma;
her heart went into atrial fibrillation (AFib) and heart rate was up to 155; This is a spontaneous report from a contactable consumer (patient).  A 71-year-old female patient received her first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 at single dose for covid-19 immunisation.  Medical history included blood cholesterol abnormal, atrial fibrillation and ongoing high blood pressure.Concomitant medication included losartan for high blood pressure, atorvastatin for cholesterol, gabapentin, hydrochlorothiazide (HYDROCHLORZIDE). The patient experienced her heart went into atrial fibrillation (AFib) and heart rate was up to 155 on 20Jan2021 with outcome of unknown. The patient went to the hospital last night on 20Jan2021 and corona virus test that was negative last night.The patient stated she was still in the hospital, until 21Jan2021. (Dates of hospitalization was not available over the call, hence hospitalization was checked as seriousness criteria). The patient received a medicine that they put in the drip, IV, to lower her heart rate.   Information about lot/batch number has been requested.
6/20/22 I got an ocular migraine. I lost vision in my left eye for approximately 45 minutes. I took a Tylenol and an aspirin in case I was having a stroke. I had no pain, just an aura. I took my blood pressure, and it was okay, but elevated.  I called the doctor the next day. They told me to go to the Emergency Room. At the Emergency Room they did a whole work up on me.  All tests were normal. My blood pressure was a little elevated, but I am on blood pressure medicine. They increased my dosage of Losartan. I saw an Eye Doctor the following day. I was examined and everything looked good.
Site: Pain at Injection Site-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Additional Details: Patient stated numbness in 2 fingers after injection
This spontaneous report as received from a registered nurse refers to an unspecified number of patients received GARDASIL (Lot #, dose and route not reported) outside of the prescribed dosing schedule. No adverse events reported. No identifying patient information provided. It was not known if these patient sought for medical attention. Additional information has been requested.
Within 24 hours of the vaccine, the patient exhibits excessive bleeding, usually in the form of a bloody nose. This has happened with all 5 doses, but this is the first time I was aware I could report the reaction. The patient has experienced severe bloody noses and bleeding gums after every DTaP shot, with the bloody noses being very heavy in flow, they start extremely easily or with no provocation, and occur frequently throughout the day. This begins within 24 hours of the injection, and lasts about 1-2 weeks. It has gotten worse with each dose, and has now also occurred with the Hib vaccine given about 2-3 weeks after this recent reaction. Nose bleeds will finally stop with an Icepack applied to the base of the skull.
10 am  3/25 - chills, headache, cough, aches, pains temperature steady at 103.9. extremely tired vaccinated arm swollen and sore 10/26 - headache, chills, temp steady at 99..9, extremely tired, vaccinated arm swollen and sore
Patient fainted after injection of PROQUAD (MMRV) and KINRIX (IPV-DTaP). HR dropped to 67. Pt. was pale, dusky. Required stimulation. Sats 97% - 100% RA. Returned to nl activity within 10 minutes.
Loss of use right leg.  Paralysis, numbness, tingling, severe pain, and muscle spasms. Acute onset without other trauma
At 1635 client approached EMTs to let them know she was feeling chills and warmth. EMT gave client water and snack. PHN  joined at 1640. Upon arrival client sitting upright in chair, alert and oriented x4. Client reported history of hypertension, current medications estrogen and "one pill for hypertension" and severe allergy to penicillin.  PHN observed client's face flushing. Client reported feeling itchy on face. Client denied shortness of breath, throat closing. PHN  offered client Bendaryl, client advised on Benadryl causing drowsiness. Client declined due to not having anyone to pick her up. PHN offered client paramedics and client declined. Vitals at 1647 by EMT: blood pressure 132/88, pulse 79, oxygen sat 100%. Client reported itchiness spreading to chest and left arm. Vitals at 1654: blood pressure 136/90, pulse 80, oxygen sat 100%. PHN offered client Benadryl again and client accepted. PHN administered 50mg Benadryl orally at 1657. Vitals at 1701: blood pressure 136/88, pulse 78, oxygen sat 100%. Client reported chills has resolved. Itchiness of face and left arm the same. Vitals at 1707: blood pressure 140/90, pulse 78, oxygen sat 100%. Per client itchiness still present but improving. Vitals at 1713: blood pressure 142/90, pulse 83, oxygen sat 100%. Per client some itchiness still in face and at site of vaccination in left arm. Flushing of face improving. Vitals at 1717: blood pressure 140/90, pulse 79, oxygen sat 100%. Client reported feeling "better". PHN advised client to follow up with provider and gave ER precautions. Last vitals at 1723: blood pressure 138/86, pulse 73, oxygen sat 100%. Per client feeling "fine to drive" and that she lives less than 10 mins away. PHN discussed with client if someone could pick her up, taxi, or Uber due to drowsiness. Client left facility against medical advise regarding driving at 1724 with steady gait.
Lightheaded and dizzy for half an hour around 2:30 AM Headache and achey legs for the next 24 hours after that Sore arm for 72 hours after injection
We held an immunization for our overnight associates at our store. She explained that several hours after receiving vaccine she felt pain in her arm and nauseated. She finished shift and went home - went right to sleep and later woke up with lots of pain in arm and vomiting. Her husband took her to the urgent care.  While there she was given a dose of Morphine and also something for inflammation. They also gave he medication for nausea/vomiting and later she was discharged.
body went from cold to warm; feet and face swollen; feet and face swollen; tired; weak; acid reflux; flu like symptom; chills; nausea; arm hurt, I taught it was going to fall off; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Apr-2021 and was forwarded to Moderna on 24-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt, I taught it was going to fall off), FEELING ABNORMAL (body went from cold to warm), SWELLING FACE (feet and face swollen), PERIPHERAL SWELLING (feet and face swollen) and FATIGUE (tired) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LANSOPRAZOLE, FAMOTIDINE and LACTOBACILLUS NOS (CULTURELLE) for an unknown indication.    On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm hurt, I taught it was going to fall off). On an unknown date, the patient experienced FEELING ABNORMAL (body went from cold to warm), SWELLING FACE (feet and face swollen), PERIPHERAL SWELLING (feet and face swollen), FATIGUE (tired), ASTHENIA (weak), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux), INFLUENZA LIKE ILLNESS (flu like symptom), CHILLS (chills) and NAUSEA (nausea). At the time of the report, PAIN IN EXTREMITY (arm hurt, I taught it was going to fall off), FEELING ABNORMAL (body went from cold to warm), SWELLING FACE (feet and face swollen), PERIPHERAL SWELLING (feet and face swollen), FATIGUE (tired), ASTHENIA (weak), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux), INFLUENZA LIKE ILLNESS (flu like symptom), CHILLS (chills) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took Tylenol for treatment.
Patient observed a large bump, 1-inch in diameter on the injection site. It was also itchy and hard. She observed this reaction on 3-16-17. She was put on doxycycline and states that she is better.
discomfort w/inject noticed in evening & swelling redness hot to touch all upper arm;
I don?t know if the number (above ) is accurate; it is the only one on my Vaccination Record Card Within 48 hours of receiving the shot I developed a large red circular mark, over a raised painful lump. At the injection site.  The lump and the mark grew larger?circumference about 5 inches?over the next few days.   It was painful to the touch and itched.  I did not see a doctor.  I read what I could find about ?Covid arm? and followed the advice rendered.  Today, one week after the injection, there is only a slight bump and a slight itch.
Within 5 minutes, searing and debilitating lower back pain.  Unable to walk, lasted approximately 10 minutes, was relieved by sitting.  Went to ER via ambulance, differential dx of disc slippage and leaking aortic aneurysm ruled out, discharged with no clear explanation of pain.  Later symptoms of fever (101), chills, muscle aches and fatigue started seven hours post injection., subsiding next day.
Pt experienced flu like symptoms for at least 2 days I know of. I believe it started a day or two after the PREVNAR 13 was given. On 10/2 and 10/4 she was not feeling good, nose drips, exhausted, flu-like symptoms.
Our baby got Bexsero vaccines 3 times; Our baby got Bexsero vaccines 3 times instead of 2; This case was reported by a consumer via interactive digital media and described the occurrence of inappropriate age at vaccine administration in a patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis, Men B NVS (Bexsero) for prophylaxis, meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis, Men B NVS (Bexsero) for prophylaxis and meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero, Bexsero Pre-Filled Syringe Device, the 2nd dose of Bexsero, Bexsero Pre-Filled Syringe Device, the 3rd dose of Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero, Bexsero Pre-Filled Syringe Device, Bexsero, Bexsero Pre-Filled Syringe Device, Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and extra dose administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and extra dose administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The case was reported by the patient's parent. The age at vaccination was not provided. The reporter stated that, patient received Bexsero vaccines 3 times instead of 2 because they moved to another country, which led to inappropriate age at vaccine administration and extra dose administered. No further information was reported.   Note-As no age was reported for the patient and as only baby was reported, hence conservatively inappropriate age at vaccine administration was captured as event
Patient developed intermittent chest pain 2 days after receiving her 2nd dose of Pfizer covid vaccine.  She was seen in the ER on 1/17/2021.  Pt improving.  Seen for follow up by PCP on 1/19/21.  Pt called office on 1/21/2021 - ongoing intermittent chest pain. Will see Cardiology.
Saturday June 5th  Pain in left arm that spread to a bigger area. Sunday, June 6th  All Day Body aches (muscles and joints), head ache, fatigue, labored breathing, chills,  nausea and diarrhea Overnight sweats Monday, June 7th  I still have fatigue, labored breathing and diarrhea.  Everything else is lessened (pain in left arm)  Gone are all of the aches and chills and nausea
15 minutes after injection, I had a strong metallic taste in my mouth.  One hour to 1.5 hours after the injection, my tongue felt scalded .  My tongue has an obvious red ring which continues to have a burning sensation.   Day 3 and it is somewhat less sensitive but continues to burn.
Headache fatigue, headache, swollen arm at injection site, body aches and weakness Narrative:
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose12/30/21 2nd dose01/21/21 Diagnosed covid positive:09/15/21 Symptom onset:09/13/21 Exposure:community Symptoms:cough,fatigue,runny nose, HA
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 31-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 28Sep2021 as dose 3 (booster), single (Lot number: FD0809) at the age of 31 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Allergies to Dogs/Cats" (unspecified if ongoing); "Allergies to Dustmites" (unspecified if ongoing); "GERD" (unspecified if ongoing); "Anxiety" (unspecified if ongoing). Concomitant medication(s) included: MONTELUKAST; SPIRONOLACTONE; ESCITALOPRAM; OMEPRAZOLE; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; ALBUTEROL [SALBUTAMOL]. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" (09Jul2022) and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (29Jun2022) covid positive line faded to almost invisible; (01Jul2022) positive, notes: covid positive line faded to almost invisible by 29Jun2022 but strongly visible on 01Jul2022; (09Jul2022) slowly faded, notes: covid positive line faded to almost invisible by 29Jun2022 but strongly visible on 01Jul2022 and slowly faded until 09Jul2022 when it was no longer visible (tested every 2 days). Therapeutic measures were taken as a result of drug ineffective, covid-19 with anti-viral medications of Paxlovid (Lot number: GC4027) for treatment of COVID-19 from 22Jun2022 to 27Jul2022. Additional information: Other medication within 2 weeks: Montelukast (Brand Camber), Spironolactone (Brand: Amneal), Escitalopram (Brand: Lupin), Omeprazole (Brand: Zydus), Zyrtec and Albuterol.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events and the use of suspect product BNT162B2 cannot be fully excluded.
I am 8 months pregnant, no current health complications. I received my Moderna booster on 12/30/2021 and woke up Friday, January 7, 2022 feeling a little dizzy and my right ear felt clogged with a loud humming. This has continues and not gone away. No history or HP and the only medication I have been on since the start of my pregnant is a thyroid medication.
A report was received from a health care professional on 13OCT2003 concerning a 58 year old male vaccinee who inadvertently received expired 2002-2003 formulation of Fluvirin on 13OCT2003. The vaccinee had experienced no adverse reaction at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Site: Pain at Injection Site-Severe, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-, Additional Details: Pt reports severe arm pain; patient thinks vaccine may have been administered too high and injured her shoulder
Pts mom stated on 4SEP91 that p/6mo dose of DTp on 8APR91, mom had to take pt to ER-t106 R; Pt recvd DT on 4SEP91;
Case number PHEH2016US023438, is an initial spontaneous report received from a nurse on 13 Sep 2016. This report refers to a 30 years old patient of unknown gender. Medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1515701) at a dose of 0.5 ml intramuscularly in right arm on 01 Dec 2015. On 01 Dec 2015, FLUVIRIN MDV that had been exposed to 8 to 10 temperature excursions was administered to patient. The nurse stated that, no adverse event was reported following this administration error (incorrect product storage). The case was assessed as non serious by the nurse.
Pfizer vaccine was given in the right deltoid.  Almost immediately after receiving the pfizer dose 1 in pts left arm, pt felt arm lock up and he could not extend his arm from the elbow.  After about 10 seconds, he regained use of his arm and was able to shake his arm around.  Pt also complained of muscle spasms in his shoulder a few minutes later.  After waiting 15 minutes in the waiting area, pt said he felt fine and was left under his own power without complaint.
Began w/ 2 large red, raised areas on inner thighs & then spread to legs, feet, hands, face; Seen in ER 9NOV91 & 10NOV91 & dx as having erythema multform;
Fist size swelling at injection site; 3 day fever 103; weakness; aches muscle and joints;
received the second dose / after the maximum recommended time of 6 months / first dose was administered / during Nov 23rd 2019; This case was reported by a pharmacist and described the occurrence of drug dose administration interval too long in a 79-year-old male patient who received Herpes zoster (Shingrix) (batch number 7f94c, expiry date 11th November 2022) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 23rd November 2019).   On 2nd July 2021, the patient received the 2nd dose of Shingrix. On 2nd July 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The patient received the 2nd dose of Shingrix after the maximum recommended time of 6 months, which led to lengthening of vaccination schedule. The reporter consented to follow up. The case is linked with the case- US2021143505, reported by the same reporter.   Follow- up information was received on 9th July 2021: Upon follow up case classification was changed to "FU NO - Permission Denied" as unable to contact reporter due to incorrect phone number/ no longer in service.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021143505:Same reporter
I woke up at 11:30 pm with massive sweating and shaking.  My heart rate was over 140 BPM and did not go back to normal until about 5 am.   I was short of breath for about the first hour from waking up.   I thought I was dying.
Elevated BP. Itching on neck, injection site arm, chest, and face. Hives present on arm, chest and neck.
This spontaneous report was received from a healthcare worker referring to a 6 month old patient of unknown gender. The patients' concurrent conditions and medical histories were not provided. On 16-OCT-2015, the patient was vaccinated with a dose of improperly stored ROTATEQ orally (dose was unknown, lot # K023532, expiration date 21-JUN-2016). Concomitant medication was not reported. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Congestion, fatigue, fever, body aches, diarrhea, shortness of breath
Military member received Anthrax vaccine #2 on 16 Sept 2007.  Approx 24 hours later he describes pruritic hives over arms, trunk, legs.  Denies SOB and airway edema.  OTC Diphenhydramine effective.  Complete resolution within one week.  Did not seek medical attention.
Employee began feeling shaky and faint about 5 minutes after receiving Johnson and Johnson COVID vaccine. She was immediately wheeled over to the emergency room
Itchy blisters on back and under arm, Chills without fever. Doctor identified as shingles.
pt stopped breathing, fever transported via amb to hosp-kept overnoc-until fever dec;
The patient was given the vaccine. During the 15-minute observation period the patient became lightheaded, blacked out and slid out of the chair he was sitting in. The patient was asked to lay down. The patient asked for water and chocolate and was given both. Emergency medical services were called (fire department). The firemen took the patient's blood pressure and asked if he wanted to be taken to the hospital. The patient refused to be transported to the hospital. The patient was then asked to remain seated for an additional 10 minutes and was picked up from the pharmacy by his friend.